Denise Wolf

7PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 22, 2026
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.

|Feb 27, 2026
Characterization of the somatic landscape and transcriptional profile of breast tumors from 748 Hispanic/Latina women in California.

Yuan Chun Ding, Rosalyn W Sayaman, Denise Wolf

|Sep 04, 2025
Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.

Emmanuel F Petricoin, Denise M Wolf, Christina Yau

|Jun 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.

Denise M Wolf, Christina Yau, Michael Campbell

|Nov 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers.

Alejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai

|Mar 12, 2024
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy.

Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman

Pageof 2

Frequent Collaborators

6 joint publications

Laura Van't Veer

6 joint publications

Gillian L Hirst

6 joint publications

Laura J Esserman

5 joint publications

Christina Yau